Question 1

What is the analyst consensus rating for BLTE?

Accepted Answer

The analyst consensus rating for BLTE is "Strong Buy" based on 5 analyst recommendations.

Question 2

What is the average price target for BLTE?

Accepted Answer

The average 12-month price target for BLTE is $183.80, representing an upside of 4.5% from the current price of $175.84.

Question 3

What do analyst ratings mean?

Accepted Answer

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

Question 4

What is a price target?

Accepted Answer

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.

Date	Analyst	Firm	Action	Rating	Price Target
Jan 28, 2026	Yi Chen	HC Wainwright	Reiterates	Strong Buy	$185.00 → $185.00 +0.00 (0.0%)
Jan 26, 2026	Tazeen Ahmad	BofA Securities	Initiates	Strong Buy	$195.00
Jan 6, 2026	Judah Frommer	Morgan Stanley	Initiates	Buy	$191.00
Dec 2, 2025	Graig Suvannavejh	Mizuho	Upgrades	Buy	$105.00 → $194.00 +89.00 (84.8%)
Dec 1, 2025	Yi Chen	HC Wainwright	Maintains	Strong Buy	$98.00 → $185.00 +87.00 (88.8%)
Nov 24, 2025	Steve Seedhouse	Cantor Fitzgerald	Initiates	Buy	$154.00
Nov 20, 2025	Graig Suvannavejh	Mizuho	Initiates	Hold	$105.00

Belite Bio (BLTE) Stock Analyst Forecast

Analyst Consensus Rating

Consensus Rating

Average Price Target

Latest BLTE Analyst Ratings & Recommendations